Partnering with a surging number of CROs, CMOs, CSOs, and other niche providers, biopharm companies in 2007 will have an estimated spend of more than $7 billion on international clinical trial outsourcing alone.
Harry Atkins
Advertisement
Articles by Harry Atkins
Advertisement
Latest Updated Articles
Outsourcing Virtually Everything: Making the Semi-Virtual Model WorkPublished: April 2nd 2007 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
Analytics, Automation, and Quality Driving the Next Era of Drug Development
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
5
